EBR:AGFB - Euronext Brussels - BE0003755692 - Common Stock - Currency: EUR
EBR:AGFB (5/22/2025, 5:24:32 PM)
0.906
+0.01 (+0.67%)
The current stock price of AGFB.BR is 0.906 EUR. In the past month the price increased by 2.74%. In the past year, price decreased by -17.13%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
NXU.DE | NEXUS AG | 40.78 | 1.26B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 42.38 | 1.18B | ||
EQS.PA | EQUASENS | 21.26 | 770.64M | ||
CONTX.OL | CONTEXTVISION AB | 14.18 | 372.92M | ||
GPI.MI | GPI SPA | 2.87 | 298.35M | ||
CGM.PA | CEGEDIM SA | N/A | 163.56M | ||
AJ91.DE | DOCCHECK AG | 25.21 | 61.35M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 42.47M | ||
ALINS.PA | INTRASENSE SAS | N/A | 14.66M | ||
MLLAB.PA | MEDIA LAB SPA | N/A | 5.26M |
Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital systems for the printing industry, the healthcare sector, and specific industrial applications. The company is headquartered in Mortsel, Antwerpen and currently employs 4,741 full-time employees. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The firm is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.
AGFA-GEVAERT NV
Septestraat 27
Mortsel ANTWERPEN BE
Employees: 4765
Phone: 3234442111
The current stock price of AGFB.BR is 0.906 EUR. The price increased by 0.67% in the last trading session.
The exchange symbol of AGFA-GEVAERT NV is AGFB and it is listed on the Euronext Brussels exchange.
AGFB.BR stock is listed on the Euronext Brussels exchange.
9 analysts have analysed AGFB.BR and the average price target is 1.19 EUR. This implies a price increase of 31.35% is expected in the next year compared to the current price of 0.906. Check the AGFA-GEVAERT NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AGFA-GEVAERT NV (AGFB.BR) has a market capitalization of 140.27M EUR. This makes AGFB.BR a Micro Cap stock.
AGFA-GEVAERT NV (AGFB.BR) currently has 4765 employees.
AGFA-GEVAERT NV (AGFB.BR) has a support level at 0.81 and a resistance level at 0.91. Check the full technical report for a detailed analysis of AGFB.BR support and resistance levels.
The Revenue of AGFA-GEVAERT NV (AGFB.BR) is expected to grow by 2.32% in the next year. Check the estimates tab for more information on the AGFB.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AGFB.BR does not pay a dividend.
AGFA-GEVAERT NV (AGFB.BR) will report earnings on 2025-08-27.
AGFA-GEVAERT NV (AGFB.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.58).
ChartMill assigns a technical rating of 4 / 10 to AGFB.BR. When comparing the yearly performance of all stocks, AGFB.BR is a bad performer in the overall market: 82.35% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR. While AGFB.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months AGFB.BR reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 11.27% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -6.75% | ||
ROE | -28.88% | ||
Debt/Equity | 0.44 |
ChartMill assigns a Buy % Consensus number of 76% to AGFB.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 112.7% and a revenue growth 2.32% for AGFB.BR